Priska Vonbach
YOU?
Author Swipe
View article: Impact of a clinical decision support system on paediatric drug dose prescribing: a randomised within-subject simulation trial
Impact of a clinical decision support system on paediatric drug dose prescribing: a randomised within-subject simulation trial Open
Background Drug dosing errors are among the most frequent causes of preventable harm in paediatrics. Due to the complexity of paediatric pharmacotherapy and the working conditions in healthcare, it is not surprising that human factor is a …
View article: Digitalisation of the drug prescribing process in Swiss hospitals – results of a survey
Digitalisation of the drug prescribing process in Swiss hospitals – results of a survey Open
The digitalisation of the medical prescribing process in Swiss hospitals has progressed over the last decade. Drug prescriptions via electronic prescribing systems were introduced in most hospitals. However, this survey suggests that the c…
View article: Pharmacokinetics and tolerability of intranasal or intravenous administration of nalbuphine in infants
Pharmacokinetics and tolerability of intranasal or intravenous administration of nalbuphine in infants Open
Objectives Intranasal nalbuphine could be a safe, efficacious and non-invasive alternative to parenteral pain medication in infants. We aimed to assess pharmacokinetics (PK) and tolerability of intranasal and intravenous nalbuphine adminis…
View article: Pharmacometric Analysis of Intranasal and Intravenous Nalbuphine to Optimize Pain Management in Infants
Pharmacometric Analysis of Intranasal and Intravenous Nalbuphine to Optimize Pain Management in Infants Open
Objectives The objective of this pharmacometric (PMX) study was to (i) characterize population pharmacokinetics (PPK) and exposure-pain response associations following intranasal (0.1 mg/kg) or intravenous (IV, 0.05 mg/kg) administration o…
View article: P78 Pharmacokinetics of intravenous and intranasal nalbuphine in infants
P78 Pharmacokinetics of intravenous and intranasal nalbuphine in infants Open
Background Nalbuphine is a mixed agonist-antagonist opioid analgesic agent frequently used in paediatrics, and licensed for parenteral use only. Intranasal delivery could be a safe, effective and non-invasive alternative, especially in inf…
View article: Evaluation of Incompatible Coadministration of Continuous Intravenous Infusions in a Pediatric/Neonatal Intensive Care Unit
Evaluation of Incompatible Coadministration of Continuous Intravenous Infusions in a Pediatric/Neonatal Intensive Care Unit Open
OBJECTIVES We aimed to evaluate and quantify incompatible coadministrations of continuous intravenous medication in the daily clinical practice of a PICU/NICU. METHODS We conducted a retrospective, observational study in the setting of an …